Ambu Valuation Multiples

Ambu is valued at $3.1B as of October 2026, a 3.2x revenue multiple. In the last 12 months, Ambu revenue was $973M and Ambu EBITDA was $183M.

See full Ambu profile

Ambu Overview

About Ambu

Ambu AS provides medical technology solutions. The company’s business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.


Founded

1937

HQ

Denmark

Employees

5.0K

Website

ambu.com

Financials (LTM)

Revenue: $973M
EBITDA: $183M

EV

$3.1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ambu Financials

Ambu reported last 12-month revenue of $973M and EBITDA of $183M.

In the same LTM period, Ambu generated $586M in gross profit, $183M in EBITDA, and $96M in net income.

Revenue (LTM)


Ambu P&L

In the most recent fiscal year, Ambu reported revenue of $906M and EBITDA of $171M.

Ambu is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 19%, and net margin of 10%.

See analyst estimates for Ambu
LTMLast FY202320242025202620272028
Revenue$973M$906M$766M$863M$921M
Gross Profit$586M$545M$440M$514M$554M
Gross Margin60%60%58%60%60%
EBITDA$183M$171M$95M$122M$174M
EBITDA Margin19%19%12%14%19%
EBIT Margin13%13%8%12%13%
Net Profit$96M$91M$29M$51M$92M
Net Margin10%10%4%6%10%
Net Debt-($117M)---

Financial data powered by Morningstar, Inc.

Ambu Stock Performance

Ambu has current market cap of $3.1B, and enterprise value of $3.1B.

Market Cap Evolution


Ambu's stock price is $11.90.

Ambu share price increased by 13.5% in the last 30 days, and decreased by 23.7% in the last year.

Ambu has an EPS (earnings per share) of $0.35.

See more trading valuation data for Ambu
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3.1B$3.1B-0.5%13.5%6.7%-23.7%$0.35

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ambu Valuation Multiples

Ambu trades at 3.2x EV/Revenue multiple, and 16.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Ambu

EV / Revenue (LTM)


Ambu Financial Valuation Multiples

As of October 24, 2026, Ambu has market cap of $3.1B and EV of $3.1B.

Ambu has a P/E ratio of 32.1x.

LTMLast FY202320242025202620272028
EV/Revenue3.2x3.4x4.0x3.6x3.3x
EV/EBITDA16.8x18.0x32.3x25.3x17.8x
EV/EBIT23.6x26.2x51.2x29.2x25.6x
EV/Gross Profit5.3x5.7x7.0x6.0x5.6x
P/E32.1x33.9x108.0x60.8x33.6x
EV/FCF40.9x39.2x72.1x37.9x39.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ambu Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ambu Margins & Growth Rates

Ambu grew revenue by 7% and EBITDA by 6% in the last fiscal year.

In the most recent fiscal year, Ambu reported gross margin of 60%, EBITDA margin of 19%, and net margin of 10%.

See estimated margins and future growth rates for Ambu

Ambu Margins

Last FY202420252026202720282029
Gross Margin60%60%60%60%
EBITDA Margin19%14%19%19%
EBIT Margin13%12%13%14%
Net Margin10%6%10%10%
FCF Margin9%9%8%8%

Ambu Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%13%7%8%
Gross Profit Growth7%17%8%8%
EBITDA Growth6%28%42%9%
EBIT Growth9%75%14%13%
Net Profit Growth4%78%81%10%
FCF Growth(5%)91%(5%)(0%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ambu Operational KPIs

Ambu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Ambu's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ambu's Rule of X is 39% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Ambu
LTMLast FY202320242025202620272028
Rule of 4031%27%---
Bessemer Rule of X49%39%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue29%30%31%29%30%
G&A Expenses to Revenue12%12%12%12%12%
R&D Expenses to Revenue6%6%6%6%6%
Opex to Revenue-47%50%47%48%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Imricor Medical Systems$292K($26M)10568.0x1603.9x(120.2x)(115.3x)
Autobio Diagnostics$634M$254M4.5x4.3x11.2x11.5x
AtriCure$535M$12M5.4x4.9x246.7x35.2x
Medacta Group$767M$220M4.2x3.8x14.5x13.8x
Lepu Medical Technology$972M$294M4.0x4.0x13.3x15.6x
Oxford Nanopore Technologies$300M($133M)8.6x7.4x(19.4x)(41.5x)
Carl Zeiss Meditec$2.5B$382M1.4x1.5x9.5x11.5x
Ottobock$1.9B$423M2.6x2.4x11.4x9.4x

This data is available for Pro users. Sign up to see all Ambu competitors and their valuation data.

Start Free Trial

Acquisitions by Ambu

Ambu has acquired 3 companies to date.

Last acquisition by Ambu was on September 14th 2026. Ambu acquired Foresight Imaging for $45M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Ambu

Foresight Imaging
invendo medical
ETView Medical
Description
Foresight Imaging is a hardware manufacturer that produces frame grabbers and video streaming devices for medical, defense, and research imaging needs.
invendo medical is a Germany-based developer of disposable, flexible endoscopy products for gastroenterology procedures. The company targets improvements in patient compliance to boost procedure volumes by prioritizing maneuverability over optical enhancements alone. invendo medical distributes single-use endoscopes designed for enhanced usability in diagnostic and therapeutic applications across global markets.
-
HQ CountryUnited StatesGermanyIsrael
HQ City
Chelmsford, MA
Kissing
Misgav
Deal Date14 Sep 202625 Oct 201723 Jun 2016
Valuation$45M$243M$16M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ambu acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ambu

When was Ambu founded?Ambu was founded in 1937.
Where is Ambu headquartered?Ambu is headquartered in Denmark.
How many employees does Ambu have?As of today, Ambu has over 5K employees.
Is Ambu publicly listed?Yes, Ambu is a public company listed on Nasdaq Copenhagen.
What is the stock symbol of Ambu?Ambu trades under AMBU B ticker.
When did Ambu go public?Ambu went public in 1993.
Who are competitors of Ambu?Ambu main competitors include Imricor Medical Systems, Autobio Diagnostics, AtriCure, Medacta Group, Lepu Medical Technology, Oxford Nanopore Technologies, Carl Zeiss Meditec, Ottobock, Tecan Group, Mirion.
What is the current market cap of Ambu?Ambu's current market cap is $3.1B.
What is the current revenue of Ambu?Ambu's last 12 months revenue is $973M.
What is the current revenue growth of Ambu?Ambu revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of Ambu?Current revenue multiple of Ambu is 3.2x.
What is the current EBITDA of Ambu?Ambu's last 12 months EBITDA is $183M.
What is Ambu's EBITDA margin?Ambu's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of Ambu?Current EBITDA multiple of Ambu is 16.8x.
What is the current FCF of Ambu?Ambu's last 12 months FCF is $75M.
What is Ambu's FCF margin?Ambu's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Ambu?Current FCF multiple of Ambu is 40.9x.
How many companies Ambu has acquired to date?As of October 2026, Ambu has acquired 3 companies.
What was the largest acquisition by Ambu?$243M acquisition of invendo medical on 25th October 2017 was the largest M&A Ambu has done to date.
What companies Ambu acquired?Ambu acquired invendo medical, Foresight Imaging, and ETView Medical.
In how many companies Ambu has invested to date?Ambu hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Ambu

Lists including Ambu

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial